Company intelligence / Profile preview

ShanMukha Innovations

Bengaluru, Karnataka, Indiasminnovations.in ↗

Ownership: Private
Development stage: Commercial

Overview

ShanMukha Innovations has launched India's first indigenously developed CDSCO-approved point-of-care test for sickle-cell anemia ("Sicklecert®") and operates mobile labs for infectious disease testing. Their solutions are deployed with government initiatives such as the National Sickle Cell Anemia Elimination Mission to screen millions across India. The company has also received awards for its COVID‑19 diagnostic innovations.

Therapeutic areas: OtherInfectious DiseasesHematology
Modalities: DeviceDiagnostic kit (Point-of-care diagnostic)Digital health platform
Industry: Molecular Diagnostics

Partnerships

Indian Institute of ScienceIIT TirupatiGovernment of India’s National Sickle Cell Anemia Elimination MissionNGOsvarious state governments in India.

Beyond the preview

Go deeper on ShanMukha Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ShanMukha Innovations.

Explore the full profile